| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514474000 | Ascorbic acid or derivative (e.g., vitamin C, etc.) | 51 |
| 20080207748 | VITAMIN C PREPARATION - The present invention relates to vitamin C preparations which enhance absorption of vitamin C into cells, and prolong the retention of vitamin C within the blood plasma and tissue of mammals, such as humans. The vitamin C preparations of the present invention include lipophilic molecules which improve the absorption of vitamin C resulting in higher plasma and cellular levels. | 08-28-2008 |
| 20080287533 | Ascorbic Acid - Natural Sugar Lactone Esters for Comprehensive Skin & Scalp Care - This invention relates to esters of ascorbic acid with natural sugar lactones [formula (I)], which are useful for the treatment of skin condition, including age spots, acne, loss of cellular antioxidants, collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles including fine lines, oxidation, damage from radiation, malfunction of matrix metalloproteases, malfunction of tyrosinases, damage from free radicals, damage from UV, dry skin, xerosis, ichthyosis, dandruff, brownish spots, keratoses, melasma, lentigines, liver spots, pigmented spots, dark circles under the eyes, skin pigmentation including darkened skin, blemishes, oily skin, warts, eczema, pruritic skin, psoriasis, inflammatory dermatoses, topical inflammation, disturbed keratinization, skin changes associated with aging, nail or skin requiring cleansers, conditioning or treatment, and hair or scalp requiring shampooing or conditioning, and combinations thereof; | 11-20-2008 |
| 20080319058 | Skin Care Products, As Well As Foods And Beverages Containing 6-O-Pufa Ascorbic Esters - Skin care products which contain as a vitamin C component 6-O-PUFA ascorbates represented by general formula (I): | 12-25-2008 |
| 20080319059 | Caffeic Acid Derivative and Composition Containing the Same - A caffeic acid derivative can be denoted by the chemical formula 1 below. | 12-25-2008 |
| 20080319060 | COMPOSITION CONTAINING VITAMIN C - The present invention relates to a composition containing vitamin C. The composition according to the present invention includes cationic material and anionic material as a primary stabilizing agent of the vitamin C; and a caffeic acid derivative as a secondary stabilizing agent of the vitamin C. The caffeic acid derivative is water-soluble and, preferably, a new caffiec acid derivative as denoted by the chemical formula 1 below is used. According to the present invention, the cationic material and the anionic material generate an electrical double layer to stabilize the vitamin C primarily; water-soluble caffeic acid derivative stabilizes the vitamin C secondarily. Accordingly, the vitamin C is stabilized double so that the vitamin C is protected from being oxidized by air, heat and moisture. | 12-25-2008 |
| 20090018187 | Strontium (M) ascorbate, compositions containing same, method for making same and method of using same - A compound of formula (ascorbate) | 01-15-2009 |
| 20090170932 | DISINFECTANT COMPOSITIONS, METHODS AND SYSTEMS - Disinfectant compositions comprising N-Acetyl Cysteine (NAC) and Vitamin C are disclosed. The disinfectant compositions have also demonstrated activity in inhibiting as well as killing micro-organisms responsible for generating biofilms. They are safe for human and medical uses and may be used as prophylactic preparations to reduce the proliferation of and/or eliminate existing or established infections. | 07-02-2009 |
| 20090197948 | Skin External Preparation - The present invention is to provide a skin external preparation with good moisture retention, a rough skin improving effect, and an improved feeling in use. A skin external preparation comprising a polyoxyalkylene glycol/polyethylene glycol copolymer alkyl ether derivative represented by the below-described general formula (I): | 08-06-2009 |
| 20090209640 | Prevention of and countermeasures against viral infection - The present invention relates to a method for treating viral infection, which includes administering arginine and a high dose of vitamin C. It also relates to an agent for treating viral infection, which includes arginine and coated vitamin C. | 08-20-2009 |
| 20090239945 | Oral Composition with an Antiageing Effect on the Skin - A composition which is adapted for oral consumption and which comprises: (i) a PPAR ligand; such as EPA or DHA (ii) an oestrogen receptor binding agent; such as soy isoflavones (iii) an agent that is involved in the post-translational modification of collagen; such as ascorbic acid and (iv) a carotenoid, wherein the composition is substantially free from added zinc and/or selenium, can provide an anti-ageing effect on skin and may be used to increase collagen synthesis in skin. | 09-24-2009 |
| 20090253785 | Bactericide composition - A bactericide composition kills | 10-08-2009 |
| 20090286874 | Anti-aging composition containing phloretin - An anti-aging composition containing: (a) at least one first active ingredient chosen from phloretin and its derivatives; (b) at least one second active ingredient chosen from cinnamic acid, resveratrol, retinol, ascorbic acid, tocopherol, and their derivatives; and (c) at least one non-aqueous organic solvent, with the proviso that if the composition contains ascorbic acid, water is present as a co-solvent. | 11-19-2009 |
| 20090292015 | STABLE HIGH VITAMIN C CONTENT POLYOL-IN-OIL EMULSIFIED SYSTEM AND ITS PREPARATION - The present invention is directed to a polyol-in-oil composition used to transport and stabilize Vitamin C. The composition includes 0.5 wt % to 5 wt % of at least one emulsifier, 0.1 wt % to 5 wt % of at least one stabilizer, 0.01 wt % to 20 wt % of Vitamin C, 10 wt % to 40 wt % of at least one oil component and 40 wt % to 80 wt % of at least one polyol, each based on the mass of the whole composition, wherein the proportion of water in the whole composition is less than 1 wt % and wherein Vitamin C is dissolved in the polyols and the use of this composition. | 11-26-2009 |
| 20100004329 | ALCOHOL METABOLISM ENHANCER AND ALCOHOLIC BEVERAGE - An alcohol metabolism enhancer is made from safe plant extracts and an alcoholic beverage and causes a reduced sick feeling and hangover from drinking alcohol without causing hemolysis using safe materials derived from plants. The alcohol metabolism enhancer and the alcoholic beverage include proanthocyanidins, such as pine bark extracts. | 01-07-2010 |
| 20100004330 | ANTI-OXIDATIVE CONTENT MATERIAL USED IN DRINK AND FOOD MANUFACTURING METHOD - The present invention relates to a food or drink which provides anti-ageing, anti-cancer, anti-heart disease, vision-enhancing effects of antioxidant substances. This method contains the following anti-oxidative supplements, and is added in food or drink in certain ratio. The method is as follows: adding into a fixed quantity of food or drink an appropriate quantity of the following effective content: vitamin C (water-soluble), β-carotene (lipid-soluble), lycopene (lipid-soluble), lutein (lipid-soluble) and surfactants. These supplements do not result in mutual interference of absorption and/or biological effect but are more effective in reducing free-radicals. | 01-07-2010 |
| 20100069485 | Method for maintaining freshness of fruits and vegetables - A process and a composition to extend the freshness of fruits and vegetables are disclosed. The method comprises treating fresh fruit or vegetable structures with a solution comprising organic acids including N-acetyl cysteine. | 03-18-2010 |
| 20100113590 | ADAM INHIBITOR - Disclosed is an ADAM inhibitor which enables to prevent or improve conditions caused by increase in ADAM activity. Specifically disclosed is an ascorbic acid derivative represented by the general formula (1) below or a salt thereof. [chemical formula 1] (1), wherein R represents a linear or branched alkyl group having 1 to 22 carbon atoms. | 05-06-2010 |
| 20100190847 | ORAL COMPOSITION WITH AN ANTIAGEING EFFECT ON THE SKIN - A composition which is adapted for oral consumption and which comprises: (i) a PPAR ligand; such as EPA or DHA (ii) an oestrogen receptor binding agent; such as soy isoflavones (iii) an agent that is involved in the post-translational modification of collagen; such as ascorbic acid and (iv) a carotenoid, wherein the composition is substantially free from added zinc and/or selenium, can provide an anti-ageing effect on skin and may be used to increase collagen synthesis in skin. | 07-29-2010 |
| 20100210718 | SYNERGISTIC ANTI-OXIDANT TREATMENT FOR LIPOTOXICITY AND OTHER METABOLICALLY RELATED PHENOMENA - A method for ameliorating, reducing, and/or preventing lipotoxicity-induced metabolic dysfunction in at least one cell is disclosed, said method comprising a step of contacting said at least one cell with a therapeutically effective amount of a synergistic anti-lipotoxicity cocktail, said cocktail comprising N-acetylcysteine, ascorbic acid, and resveratrol. Also disclosed is a method for treating at least one lipotoxicity-related metabolic disorder chosen from the group comprising (a) metabolic syndrome; (b) non-alcoholic steatohepatitis; (c) obesity; and (d) coronary heart disease, said method comprising the step of administering to a patient a therapeutically effective amount of an anti-lipotoxicity cocktail, said cocktail comprising N-acetylcysteine, ascorbic acid, and resveratrol. Finally, a composition for treating the effects of lipotoxicity, containing a synergistic combination of N-acetylcysteine, ascorbic acid, and resveratrol is disclosed. | 08-19-2010 |
| 20100273873 | DIRECT COMPRESSIBLE DEXTROSE - This invention relates to a direct compressible dextrose composition, a process for preparing such a direct compressible dextrose composition by compression and subsequent granulation, and processes for preparing pharmaceutical formulations or food formulations in tablet form using the direct compressible dextrose composition. The invention further concerns pharmaceutical or food formulations, which comprise the directly compressible dextrose composition, and the use of the direct compressible dextrose composition for the preparation of pharmaceutical and food formulations. | 10-28-2010 |
| 20100311828 | EXTRACTS OF SCLEROCARYA BIRREA - Provided are extracts obtained from the marula fruit ( | 12-09-2010 |
| 20110021626 | ENCAPSULATION OF VITAMIN C INTO WATER SOLUBLE DENDRIMERS - The invention relates to a conjugated dendrimer that comprises at least one water-soluble dendrimer and at least one vitamin C molecule. The conjugated dendrimer can be used e.g. for preparing cosmetic or pharmaceutical compositions. The dendrimers have a good vitamin C load capacity and are biocompatible. | 01-27-2011 |
| 20110136900 | BRUISE AMELIORATION COMPOSITION AND METHOD OF USE - A bruise amelioration composition that can be applied for one hour to an affected site, such as a bruise, contusion or blister, in the form of a gel, liquid or adhesive bandage. The composition includes at least 40% by weight of glycerin and at least 2% by weight of primrose oil. Preferably, the composition includes a fragrance, such as peach oil and marjoram and 1% to 10% by weight of vitamins A, C, D, E and K. | 06-09-2011 |
| 20110160301 | ASCORBATE, VITAMIN K3 AND HYDROXYTOLANS IN THE TREATMENT OF CANCER - The combination of compounds of the hydroxytolan family with ascorbate plus naphthoquinone (Vitamin K3; VK3), or a quinone or semiquinone analogue of VK3, kill tumor cells, inhibit tumor growth and development, and treat cancer in subjects in need thereof. | 06-30-2011 |
| 20110166222 | VITAMIN C COMPOSITION FOR USE IN THE PREVENTION AND TREATMENT OF STRETCH MARKS, RADIATION DERMATITIS, AND OTHER SKIN CONDITIONS AND METHODS OF USING THE SAME - A formulation for a stable ascorbic acid composition which, in a simplified form, is comprised of ascorbic acid in solution with a hygroscopic compound (i.e., a substance with the ability to attract water molecules from the surrounding environment through either absorption or adsorption). Also disclosed herein are methods for the production of such compounds and methods of using such compounds in the prevention, inhibition and treatment of striae gravidarum, radiation dermatitis, rhytids, lentigoes, dyschromia, sun-damage induced hyperpigmentation, cellulite, scars and purpura, among other skin diseases or conditions. | 07-07-2011 |
| 20110172301 | Use of anti-oxidant compounds for muscle recovery - The present invention describes the use of a composition comprising a compound according to formula (1) to retain or restore muscle health: formula (1) wherein: R can be H, OH or CH | 07-14-2011 |
| 20110213030 | External Preparation For Skin - An external preparation for skin containing an alkylresorcinol and being excellent in temperature stability (especially high-temperature stability) and photostability. More particularly an external preparation for skin comprising (a) from 0.01 to 5% by mass of 4-isobutyl resorcinol or a salt thereof, and (b) from 0.01 to 5% by mass of one or more selected from L-ascorbic acid or a salt thereof and a 3-O-alkyl-L-ascorbic acid or a salt thereof. If desired, (c) one or more compounds selected from (c-1) a sterol skeleton-having compound (e.g., POE phytosterols, POE cholestanols), (c-2) a vitamin E derivative, (c-3) a compound such as polyglycerin fatty acid esters, polyoxybutene-polyglycerin alkyl ethers, sucrose fatty acid esters, and (c-4) a sorbitan skeleton-having compound may be incorporated in the preparation. | 09-01-2011 |
| 20110281943 | Topical Composition Comprising Ascorbic Acid Derivatives - The present invention discloses topical composition comprising ascorbic acid derivatives. The inventive topical composition that the ascorbic acid derivatives is homogeneously incorporated therein can make the ascorbic acid derivatives more widely used as active ingredient in skin topical formulation. | 11-17-2011 |
| 20110319486 | STABILIZED ASCORBIC ACID SOLUTIONS; METHOD OF USE THEREOF; PROCESS FOR THEIR OBTENTION; AND COMPOSITIONS COMPRISING THE SAME - This invention relates to improved solutions comprising ascorbic acid (vitamin C). These solutions may comprise as much as 15% ascorbic acid; they are stable for at least two years, without no significant development of yellowish coloration and no substantial (not more than 10%) degradation of the vitamin. The process involves sequential additions of ascorbic acid and ethoxydiglycol to a first solution of vitamin in water, which are followed by addition of propylene glycol. The stirring speed that occurs during the additions favors a process of micronization. Mild heating is used to achieve ascorbic acid concentrations equivalent to about 6% in 10% water or higher. | 12-29-2011 |
| 20120059054 | Use Of Copolymers Based On Amino-Containing Polymers As Matrix Binders In Preparing Active Compound-Containing Granules And Administration Forms - Described are matrix binders comprising copolymers based on amino-containing polymers, as well as their use in preparing active compound-containing granules and administration forms | 03-08-2012 |
| 20120184609 | VITAMIN C AND VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATMENT OF OSTEOLYSIS OR PROLONGATION OF PROSTHETIC IMPLANT - Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof. | 07-19-2012 |
| 20120289591 | Antimicrobial Compositions Containing Free Fatty Acids - The invention concerns antimicrobial compositions comprising free fatty acids emulsified with membrane lipids or hydrolysed derivatives thereof, and pharmaceutical formulations comprising same. The compositions can be used in the treatment or prophylaxis of microbial infections. They can also regulate the rate of blood clotting rendering them suitable for incorporation in catheter locking solutions and for use in wound care. | 11-15-2012 |
| 20130102661 | IRRIGATION SOLUTIONS CONTAINING ASCORBIC ACID OR ITS SALTS AND USE THEREOF - An irrigation solution containing about 15-50 mM ascorbic acid and/or a pharmaceutically acceptable salt thereof, and electrolytes, and their uses in a surgery, a surgical manipulation, a medical process or in promoting the healing of a tendon or ligament injury in a subject. | 04-25-2013 |
| 20130131162 | Vitamin C Composition for Use in the Prevention and Treatment of Stretch Marks, Radiation Dermatitis, and Other Skin Conditions and Methods of Using the Same - A formulation for a stable ascorbic acid composition which, in a simplified form, is comprised of ascorbic acid in solution with a hygroscopic compound (i.e., a substance with the ability to attract water molecules from the surrounding environment through either absorption or adsorption). Also disclosed herein are methods for the production of such compounds and methods of using such compounds in the prevention, inhibition and treatment of striae gravidarum, radiation dermatitis, rhytids, lentigoes, dyschromia, sun-damage induced hyperpigmentation, cellulite, scars and purpura, among other skin diseases or conditions. | 05-23-2013 |
| 20130131163 | Vitamin C Composition for Use in the Prevention and Treatment of Stretch Marks, Radiation Dermatitis, and Other Skin Conditions and Methods of Using the Same - A formulation for a stable ascorbic acid composition which, in a simplified form, is comprised of ascorbic acid in solution with a hygroscopic compound (i.e., a substance with the ability to attract water molecules from the surrounding environment through either absorption or adsorption). Also disclosed herein are methods for the production of such compounds and methods of using such compounds in the prevention, inhibition and treatment of striae gravidarum, radiation dermatitis, rhytids, lentigoes, dyschromia, sun-damage induced hyperpigmentation, cellulite, scars and purpura, among other skin diseases or conditions. | 05-23-2013 |
| 20130178522 | VITAMIN C AND CHROMIUM-FREE VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING AN NFKB-MEDIATED CONDITION OR DISEASE - Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NFKB-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K. | 07-11-2013 |
| 20130184337 | SODIUM ASCORBATE STIMULATION OF ELASTOGENESIS - Embodiments provide methods for using ascorbate for the stimulation of production of elastic fibers by cells. | 07-18-2013 |
| 20130237597 | EXTENDED-RELEASE SOLID ORAL DOSAGE FORM FOR HOMEOPATHIC COMPOSITIONS - Compositions including homeopathic active ingredients prepared in timed and/or extended-release dosage form are provided. In an embodiment, a time-release composition comprises an active ingredient component including at least one homeopathic component, and an excipient or carrier component including one or more hydrophilic polymers. A method for treating symptoms due to colds and/or flu is provided comprising administering an extended-release composition. | 09-12-2013 |
| 20140142175 | ANHYDROUS COSMETIC COMPOSITIONS CONTAINING ASCORBIC ACID - The disclosure relates to cosmetic compositions comprising ascorbic acid, at least two polyols, and a copolymer, wherein the composition is essentially anhydrous. The cosmetic compositions are particularly suitable for use on the face of a consumer, for example, as a facial mask. The disclosure also provides methods for improving the appearance of skin, for delivering ascorbic acid to the skin, and/or for reducing the effects and appearance of aging using the cosmetic compositions described herein. | 05-22-2014 |
| 20140148509 | STABILIZED ASCORBIC ACID SOLUTIONS; METHOD OF USE THEREOF; PROCESS FOR THEIR OBTENTION; AND COMPOSITIONS COMPRISING THE SAME - This invention relates to improved solutions comprising ascorbic acid (vitamin C). These solutions may comprise as much as 15% ascorbic acid; they are stable for at least two years, without no significant development of yellowish coloration and no substantial (not more than 10%) degradation of the vitamin. The process involves sequential additions of ascorbic acid and ethoxydiglycol to a first solution of vitamin in water, which are followed by addition of propylene glycol. The stirring speed that occurs during the additions favors a process of micronization. Mild heating is used to achieve ascorbic acid concentrations equivalent to about 6% in 10% water or higher. | 05-29-2014 |
| 20140171500 | Health promoting drink - The present invention relates a new drink formula comprising fresh marine omega-3 oil in an emulsion and antioxidants well known to be health promoting to humans, and process for the production of said drink and the use of said drink for production of a medicament. | 06-19-2014 |
| 20140200270 | VITAMINS C AND K FOR TREATING POLYCYSTIC DISEASES - Provided herein are methods for treating, preventing, or ameliorating one or more symptoms of a polycystic disease in a subject, comprising administering to the subject a therapeutically effective amount of vitamins C and K. | 07-17-2014 |
| 20140275240 | Suppression and prevention of tumors and treatment of viruses - Combinations of betaine and vitamin C are used to suppress or prevent malignant tumors or to treat viruses, e.g., by combining the two ingredients in a product consumed by a human, dog, or cat, such as an aqueous liquid such as grape juice, the ingredients being provided in containers with instructions for use, or in finished products, especially with support of tests demonstrating the effectiveness of the treatment for, e.g., preventing tumors in populations known to be at risk of developing tumors, or, treating existing cancers in combination with other cancer drugs such as anastrozole and/or fulvestrant and/or artemisinin either concurrently or sequentially to prevent the cancer from growing when the cancer drug is not being used, or in the treatment of viruses. | 09-18-2014 |
| 20150045426 | VITAMIN C COMPLEXES - A complex formed of at least one molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or a derivative covalently bonded with at least one hydrocarbon radical with formula (A) as follows: wherein: •-m 1=1, 2, 3, 4, 5 or 6; •-m 2=0, 1, 2, 3, 4, 5 or 6; and represents the site of the bond with the molecule of 5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5H-furan-2-one or derivative. Formula (I) | 02-12-2015 |
| 20150119459 | DERMAL-APPROPRIATE COMPOSITIONS AND METHODS OF USE - This invention relates to mild or weak acids and salt mixtures, such as Ascorbic acid, that when mechanically enhanced become dermal-appropriate, thereby allowing high levels of these compositions to be used in health-care, medical, pharmaceutical, nutraceutical and cosmoceutical products. | 04-30-2015 |
| 20150141503 | SOLID, COLOR-STABLE L-ASCORBIC ACID COMPOSITIONS - The present invention relates to solid, color-stable L-ascorbic acid compositions, which are in the form of a powder or granule. These improved compositions have a high amount of vitamin C and they have excellent color stability. | 05-21-2015 |
| 20160106707 | METHOD FOR OBTAINING A STABLE GEL OF HYALURONIC ACID AND OF A FREE FORM OF VITAMIN C AND/OR A SALT THEREOF - The invention relates to a process for producing an aqueous gel comprising hyaluronic acid, vitamin C, and a stabilizing agent selected from the metabisulfites. According to the invention, such a process comprises the steps of a) preparing a mixture comprising crosslinked or non-crosslinked hyaluronic acid and/or a salt thereof with a molar mass of between 1000 Da and 10 MDa, from 0.1 to 20.0% by weight of vitamin C in its acid form, or its equivalent in ascorbate derived from a vitamin C salt, from 0.01 to 1.00% by weight of a stabilizing agent selected from the metabisulfites, and an aqueous solution added so that the hyaluronic acid content is between 0.01 and 100 mg/ml, so as to form a hydrogel, and b) degassing the mixture before the hydrogel being formed is completely swollen. | 04-21-2016 |
| 20160106709 | VITAMIN C AND CHROMIUM-FREE VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING AN NFKB-MEDIATED CONDITION OR DISEASE - Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NFκB-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K. | 04-21-2016 |
| 20160136078 | Method for Stabilizing Ascorbic Acid Derivatives and the Application Thereof - This invention discloses a method for stabilizing ascorbic acid derivatives and the application thereof. The mentioned method comprises mixing ascorbic acid derivative with a non-water-in-oil composition, and the composition comprises buffer, phosphonic acid derivative and at least one alcohol. The yellowish and degradation of ascorbic acid derivative can be efficiently decreased by the mentioned method. Moreover, the mentioned method can be used in topical composition, such as toner, serum, lotion, cream. | 05-19-2016 |
| 20160158195 | REDUCTION OF EPILEPTIC SEIZURES - Compositions for use in a method of treatment, particularly for use in a method of treatment of epilepsy or an epilepsy-related disorder, are provided. Uses of the compositions are also described, along with methods for employing the compositions. The described compositions reduce the frequency and severity of epileptic seizures. | 06-09-2016 |
| 20160200500 | L-Ascorbic Acid Formulations and Methods of Use for Skin Care | 07-14-2016 |
